The board of directors at Immutep has a history of experience in the commercial strategy of Genome.One P/L, the executive chairman of NeuClone, the chairman of the board and founder of NovoNutrients, and the CEO of Maxygen. They also have a history of education from the University of Melbourne in Biochemistry and the University of Kaiserslautern in PhD studies on algal metabolism.
View all